India's pharmaceutical industry has once again found itself at the center of an international conversation after two viral social media posts by American women highlighted the striking price differences between medicines sold in the United States and India. The latest discussion began when an American woman living in India shared a video comparing the cost of a generic leukemia medication purchased in India with its price in the United States. She said the medicine, available for about ₹35 per tablet in India, is reportedly priced at nearly ₹85,000 per tablet in the US .
Calling attention to the dramatic gap, she questioned the affordability of healthcare for many American patients. The video quickly gained traction online, prompting widespread discussion about drug pricing, healthcare access, and the role of generic medicines. Many viewers pointed to India's established generic drug…
